Maintenance of antifracture efficacy over 10 years with strontium ranelate in postmenopausal osteoporosis

SUMMARY: In an open-label extension study, BMD increased continuously with strontium ranelate over 10 years in osteoporotic women (P < 0.01). Vertebral and nonvertebral fracture incidence was lower between 5 and 10 years than in a matched placebo group over 5 years (P < 0.05). Strontium ranela...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Reginster, J-Y., Kaufman, J-M., Goemaere, S., Devogelaer, J. P., Benhamou, C. L., Felsenberg, D., Diaz-Curiel, M., Brandi, M-L., Badurski, J., Wark, J., Balogh, A., Bruyère, O., Roux, C.
Format: Artigo
Langue:Inglês
Publié: Springer-Verlag 2011
Sujets:
Original Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3277702/
https://ncbi.nlm.nih.gov/pubmed/22124575
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00198-011-1847-z
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires